BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bdb Chembl2018022

2+ PubMed studies analyzed · Evidence Score: 5.8

Research Domains

Bdb Chembl2018022 has been studied across 2 research domains including 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 🧠 Focus & Attention with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bdb Chembl2018022, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

mln
2 shared targets
cediranib
2 shared targets
erlotinib
2 shared targets
canertinib
2 shared targets
vandetanib
2 shared targets
pelitinib
2 shared targets
rebastinib
2 shared targets
sp600125
2 shared targets
dovitinib
2 shared targets
foretinib
2 shared targets
Loading evidence profile...

This evidence profile for Bdb Chembl2018022 is generated deterministically from 2 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.